Selectchemie advances life sciences with global insight
With a slew of blockbuster drugs coming off-patent until 2017, the race to commercialise generic drug candidates is tight. Zurich-based Selectchemie gives its clients the edge with an intimate knowledge of the drug and nutritionals supply chains.
The company's global insight is enviable.
As a trusted partner of active pharmaceutical ingredient (API) and finished form manufacturers, dossier developers and marketing companies, Selectchemie has
in-depth expertise on existing dossiers, especially drug molecules going off-patent. Equipped with a global network of suppliers, it is ideally positioned to evaluate and develop new markets for generic drugs. This knowledge is becoming increasingly important to pharmaceutical players given tightening market conditions. "It's still difficult for European companies or South American companies to have the good contacts in Asian countries," says Dr Peter Kaufmann, Selectchemie CEO and member of the board. "Therefore, we are building bridges through our long-term relationships and local presence in the region."
Selectchemie was among the first few European companies to venture boldly into Asia. It began establishing local ties in China, Japan and India more than 40 years ago. It has broad reach among APIs and intermediate manufacturers in China and India, enabling the company to select the most suitable suppliers for specified drug formulations.
Its drug designs represent collaborative work between in-house technical staff and partners in Asia and Europe. Selectchemie has 65 experienced professionals based in Zurich and more than 130 worldwide - ranging from nutritionists, pharmacists, chemists and food engineers to regulatory affairs specialists and business development managers. It employs local staff in all of its overseas offices. The network spans 16 countries - including offices in Ningbo, Mumbai, Sao Paulo and Buenos Aires - to support the pharmaceutical industry from drug development to distribution. Selectchemie is keen on strategic partnerships in Southeast Asia to enrich its life sciences work by developing dossiers, strategic sourcing, regulatory affairs and marketing and supply.